MX2024006888A - Proteina recombinante para la enfermedad sars-cov2. - Google Patents
Proteina recombinante para la enfermedad sars-cov2.Info
- Publication number
- MX2024006888A MX2024006888A MX2024006888A MX2024006888A MX2024006888A MX 2024006888 A MX2024006888 A MX 2024006888A MX 2024006888 A MX2024006888 A MX 2024006888A MX 2024006888 A MX2024006888 A MX 2024006888A MX 2024006888 A MX2024006888 A MX 2024006888A
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- recombinant
- cov2
- sars
- recombinant protein
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 102000004856 Lectins Human genes 0.000 abstract 3
- 108090001090 Lectins Proteins 0.000 abstract 3
- 239000002523 lectin Substances 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a la proteína para el tratamiento de enfermedades infecciosas causadas por Coronaviridae. En particular, la invención se refiere a una lectina recombinante de Solerotium rolfsii para su uso en el tratamiento, reducción de la progresión y curación de la enfermedad 8AR8-00V2 en un sujeto que lo necesita. También se describen composiciones farmacéuticas que comprenden dicha Iectina recombinante de Sc!erotium rolfsii. La proteína Iectina recombinante de Sc!erotíum rolfsii puede comprender una secuencia de aminoácidos que tiene al menos un 70 % de homología con la SEQ ID N0:1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121058651 | 2021-12-16 | ||
| PCT/IB2022/062211 WO2023111892A1 (en) | 2021-12-16 | 2022-12-14 | Recombinant protein for treating sars-cov2 disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024006888A true MX2024006888A (es) | 2024-06-19 |
Family
ID=84981758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024006888A MX2024006888A (es) | 2021-12-16 | 2022-12-14 | Proteina recombinante para la enfermedad sars-cov2. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250041380A1 (es) |
| EP (1) | EP4447992A1 (es) |
| JP (1) | JP2024544264A (es) |
| KR (1) | KR20240122769A (es) |
| CN (1) | CN118524847A (es) |
| AU (1) | AU2022410688A1 (es) |
| CA (1) | CA3239504A1 (es) |
| MX (1) | MX2024006888A (es) |
| WO (1) | WO2023111892A1 (es) |
| ZA (1) | ZA202404498B (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2430041T3 (pl) | 2009-02-18 | 2019-09-30 | Unichem Laboratories Limited | Rekombinowane lektyny o aktywności antynowotworowej wiążące się z komórkami nowotworowymi oraz sposób ich otrzymywania |
| WO2014203261A2 (en) | 2010-02-02 | 2014-12-24 | Unichem Laboratories Ltd. | Recombinant lectin and method of preparing thereof |
| WO2020074984A1 (en) | 2018-09-16 | 2020-04-16 | Unichem Laboratories Ltd | Protein for treatment of inflammatory diseases |
| TWI775426B (zh) | 2020-05-07 | 2022-08-21 | 中央研究院 | 冠狀病毒感染之治療及預防 |
| WO2021222965A1 (en) | 2020-05-07 | 2021-11-11 | Ess Holding Gmbh | Mannose-binding lectin for treatment or prophylaxis of infectious diseases |
| US20210369811A1 (en) * | 2020-05-28 | 2021-12-02 | David M. Manyak | Integrated COVID-19 Strategies |
| CN113262294B (zh) | 2021-05-31 | 2022-03-22 | 中国食品药品检定研究院 | 一种用于治疗冠状病毒感染的植物凝集素succ-Con A及应用 |
| CN113274484B (zh) | 2021-05-31 | 2022-04-08 | 中国食品药品检定研究院 | 小扁豆凝集素在制备预防和治疗冠状病毒引起的感染性疾病的药物中的应用 |
-
2022
- 2022-12-14 US US18/718,862 patent/US20250041380A1/en active Pending
- 2022-12-14 EP EP22844265.3A patent/EP4447992A1/en active Pending
- 2022-12-14 MX MX2024006888A patent/MX2024006888A/es unknown
- 2022-12-14 CA CA3239504A patent/CA3239504A1/en active Pending
- 2022-12-14 AU AU2022410688A patent/AU2022410688A1/en active Pending
- 2022-12-14 WO PCT/IB2022/062211 patent/WO2023111892A1/en not_active Ceased
- 2022-12-14 KR KR1020247019744A patent/KR20240122769A/ko active Pending
- 2022-12-14 CN CN202280082298.8A patent/CN118524847A/zh active Pending
- 2022-12-14 JP JP2024535288A patent/JP2024544264A/ja active Pending
-
2024
- 2024-06-10 ZA ZA2024/04498A patent/ZA202404498B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118524847A (zh) | 2024-08-20 |
| WO2023111892A1 (en) | 2023-06-22 |
| EP4447992A1 (en) | 2024-10-23 |
| US20250041380A1 (en) | 2025-02-06 |
| KR20240122769A (ko) | 2024-08-13 |
| CA3239504A1 (en) | 2023-06-22 |
| AU2022410688A1 (en) | 2024-06-13 |
| ZA202404498B (en) | 2025-01-29 |
| JP2024544264A (ja) | 2024-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2563646T3 (es) | Composiciones y métodos relacionados con variantes de la proteína A (SpA) | |
| PE20231439A1 (es) | Proteinas f de hmpv estabilizadas por prefusion | |
| BR0208183A (pt) | Peptìdeo modificado por wt1 | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| EA200870237A1 (ru) | Последовательности пептидов и композиции | |
| HRP20040712B1 (hr) | Anti-amiloidna beta antitijela i njihova uporaba | |
| EA200900373A1 (ru) | Реконструированные сурфактанты, обладающие улучшенными свойствами | |
| MX2021013743A (es) | Subunidad s1 modificada de la proteina de espicula de coronavirus. | |
| BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
| EA202190310A1 (ru) | Белок для лечения воспалительных заболеваний | |
| BRPI0607097A2 (pt) | peptìdeos de papiloma vìrus l2 n-terminais para a indução de anticorpos de neutralização amplamente cruzada | |
| CO2021017664A2 (es) | Péptidos | |
| MX2022007881A (es) | Proteina f mutante del virus sincitial respiratorio (rsv) y usos de la misma. | |
| AR116876A1 (es) | Vacuna de ibv 4/91 con proteína espicular heteróloga | |
| PE20251395A1 (es) | Proteinas de fusion de hmpv de prefusion estabilizadas | |
| ECSP066495A (es) | Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv) | |
| ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
| MX2024006888A (es) | Proteina recombinante para la enfermedad sars-cov2. | |
| MX2018002616A (es) | Proteina de fusion. | |
| AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
| ATE449790T1 (de) | Rekombinante gelatinepartikel für die zelladhäsion | |
| PE20121553A1 (es) | Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una efermedad parasitaria | |
| ATE552271T1 (de) | Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon | |
| ZA202401042B (en) | Protein compositions for the treatment of inflammatory diseases | |
| MX2024008759A (es) | Peptidos y composicion farmaceutica para el tratamiento de tumores. |